BioAge Labs Inc. (BIOA): Price to Sales

Corporate company logo of BioAge Labs Inc. (BIOA)

The price-to-sales ratio dynamics for BioAge Labs, Inc. (BIOA) reflect market expectations, with the indicator reaching 30.00. BioAge Labs, Inc. (BIOA) is implementing AI for the digital analysis of aging biomarkers to reduce routine labor. The business is developing therapies for age-related pathologies, utilizing neural networks for target discovery. Product launch efficiency is being enhanced through deep outsourcing of clinical trials with leading medical vendors.

BioAge - BIOA P/S Multiple (period 05/08/2025 - 11/13/2026)

Metric breakdowns and analytics for BioAge Labs Inc. (BIOA)

- current price and projected stock value:
Price Chart bioagelabs.com|BIOA - Price Target Chart
- stock exchange capitalization data:
Market Value BioAge Labs Inc.|BIOA - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share BioAge Labs, Inc.|BIOA - Book Capitalization|Market Capitalization to Book Value bioagelabs.com|BIOA - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient BioAge Labs, Inc.|BIOA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio BioAge Labs, Inc|BIOA - Company Aggregate Debts|Debt to Book Capitalization Ratio BioAge Labs Inc.|BIOA - Company Long-Term Debts|Short-Term Debt Volume BioAge Labs, Inc.|Immediate Liquidity bioagelabs.com
- financial results and valuation multiples details:
BIOA - Net Profit|Projected Future Earnings BioAge Labs, Inc.|BIOA - P/E Multiple|Forward Price to Earnings Multiple BioAge Labs|BIOA - PEG Multiple|Company Value to EBITDA BioAge Labs Inc.|BIOA - Operating profit before deduction of amortization|Earnings per share for the trailing year BioAge Labs, Inc.|BIOA - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months bioagelabs.com|BIOA - Earnings growth in current year|Earnings growth forecast for next year BioAge Labs, Inc.
- issuer revenue and sales details:
BIOA - Revenue and Sales Volume|Company Projected Revenue bioagelabs.com|BIOA - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio BioAge Labs Inc.
General company analysis:bioagelabs.com BIOA
Core merchandise of BioAge Labs, Inc.

The P/S multiple determines the market value of one dollar of revenue, allowing for an assessment of the business premium through the ratio of market capitalization to sales volume. By analyzing the P/S multiple, an investor can see how the market values the potential of BioAge Labs, Inc. (BIOA), whose current valuation is based on internal R&D developments in metabolism prior to the receipt of initial clinical results.

Competing companies

Price-to-Revenue Ratio ASND (ascendispharma.com)|Price-to-Revenue Ratio Madrigal Pharmaceuticals, Inc. MDGL|Corcept Therapeutics Inc. (CORT) - Price to Sales|RYTM - Price-to-Revenue Ratio|AKRO: Price-to-Revenue Ratio|MTSR: P/S Multiple|MLTX - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Crinetics|NewAmsterdam Pharma Company (NAMS) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Soleno (SLNO)|Market Cap to Revenue Amicus Corp FOLD|P/S Multiple ETNB (89bio, Inc.)|agios.com - Price-to-Revenue Ratio|Structure Therapeutics Inc. - P/S Multiple|Price-to-Revenue Coefficient MiMedx Group Inc MDXG|Rezolute Corp (RZLT) - Price-to-Revenue Ratio|Price to Sales Lexicon Corp (LXRX)|MBX (MBX Biosciences Inc) - P/S Multiple|P/S Multiple altimmune.com|P/S Multiple AARD|Sagimet Biosciences, Inc. (SGMT) - Price-to-Revenue Multiple|P/S Multiple BMEA (Biomea)|Quince Therapeutics Inc (QNCX) - Price to Sales|GUTS: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio VTVT (vTv Therapeutics Inc.)|agapeatpgroup.com (ATPC) - Price-to-Revenue Ratio|PLUR (Pluri) - Price-to-Revenue Ratio|SYBX (Synlogic Inc.) - P/S Multiple|P/S Multiple Lipocine Corporation|P/S Multiple MTNB|Price-to-Revenue Ratio SPRB (sprucebiosciences.com)|Price-to-Revenue Ratio Galecto GLTO|Price-to-Revenue Coefficient Carmell Corp. (CTCX)|LUMO: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio ONVO (Organovo Corp)|RDUS: P/S Multiple